# Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

> **NCT04885829** · PHASE1 · COMPLETED · sponsor: **Syneos Health** · enrollment: 300 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Giant Cell Arteritis

## Interventions

- **DRUG:** Tocilizumab Prefilled Syringe

## Key facts

- **NCT ID:** NCT04885829
- **Lead sponsor:** Syneos Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-31
- **Primary completion:** 2023-05-04
- **Final completion:** 2023-05-04
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885829, "Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04885829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*